These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 3487899

  • 1. [Complement fragment C 3d in the plasma of patients with chronic polyarthritis].
    Stannat S, Peter HH, Raspe HH, Deicher H.
    Z Rheumatol; 1986; 45(2):47-51. PubMed ID: 3487899
    [Abstract] [Full Text] [Related]

  • 2. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.
    Mallya RK, Vergani D, Tee DE, Bevis L, de Beer FC, Berry H, Hamilton ED, Mace BE, Pepys MB.
    Clin Exp Immunol; 1982 Jun; 48(3):747-53. PubMed ID: 6981476
    [Abstract] [Full Text] [Related]

  • 3. Activation of classical pathway complement in chronic inflammation. Elevated levels of circulating C3d and C4d split products in rheumatoid arthritis and Crohn's disease.
    Petersen NE, Elmgreen J, Teisner B, Svehag SE.
    Acta Med Scand; 1988 Jun; 223(6):557-60. PubMed ID: 3389208
    [Abstract] [Full Text] [Related]

  • 4. Circulating complement breakdown products in patients with rheumatoid arthritis. Correlation between plasma C3d, circulating immune complexes, and clinical activity.
    Nydegger UE, Zubler RH, Gabay R, Joliat G, Karagevrekis CH, Lambert PH, Miescher PA.
    J Clin Invest; 1977 May; 59(5):862-8. PubMed ID: 853126
    [Abstract] [Full Text] [Related]

  • 5. [Elevated C3-proactivator serum levels in patients with chronic polyarthritis].
    Stojan B.
    Z Rheumatol; 1976 May; 35(7-8):272-7. PubMed ID: 961078
    [Abstract] [Full Text] [Related]

  • 6. Steroids reduce complement activation in rheumatoid arthritis.
    Brandslund I, Peters ND, Ejstrup L.
    Int J Tissue React; 1985 May; 7(2):161-5. PubMed ID: 3875589
    [Abstract] [Full Text] [Related]

  • 7. [Fibronectin and other immunologic parameters in chronic polyarthritis].
    Siegmeth W, Minar E, Graninger W, Pirich K, Zazgornik J.
    Z Rheumatol; 1984 May; 43(1):27-9. PubMed ID: 6201023
    [Abstract] [Full Text] [Related]

  • 8. The complement fixing ability of putative circulating immune complexes in rheumatoid arthritis and its relationship to extra-articular disease.
    Bourke BE, Moss IK, Mumford P, Horsfall A, Maini RN.
    Clin Exp Immunol; 1982 Jun; 48(3):726-32. PubMed ID: 6981475
    [Abstract] [Full Text] [Related]

  • 9. [Serum complement levels in patients with rheumatoid arthritis and vasculitis].
    Tomooka K.
    Fukuoka Igaku Zasshi; 1989 Oct; 80(10):456-66. PubMed ID: 2613159
    [Abstract] [Full Text] [Related]

  • 10. Complement activation in patients with rheumatoid arthritis mediated in part by C-reactive protein.
    Molenaar ET, Voskuyl AE, Familian A, van Mierlo GJ, Dijkmans BA, Hack CE.
    Arthritis Rheum; 2001 May; 44(5):997-1002. PubMed ID: 11352263
    [Abstract] [Full Text] [Related]

  • 11. Complement activation in bronchial asthma evaluated by the C3d/C3 index.
    Michel O, Sergysels R, Duchateau J.
    Ann Allergy; 1986 Dec; 57(6):405-8. PubMed ID: 3491553
    [Abstract] [Full Text] [Related]

  • 12. Complement C3c and C3d in plasma and synovial fluid in rheumatoid arthritis.
    Berkowicz A, Kappelgaard E, Petersen J, Nielsen H, Ingemann-Hansen T, Halkjaer-Kristensen J, Sørensen H.
    Acta Pathol Microbiol Immunol Scand C; 1983 Dec; 91(6):397-402. PubMed ID: 6608857
    [Abstract] [Full Text] [Related]

  • 13. Acute complement activation during an anaphylactoid reaction to blood transfusion and the disappearance rate of C3c and C3d from the circulation.
    Teisner B, Brandslund I, Grunnet N, Hansen LK, Thellesen J, Svehag SE.
    J Clin Lab Immunol; 1983 Oct; 12(2):63-7. PubMed ID: 6606048
    [Abstract] [Full Text] [Related]

  • 14. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway.
    Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D.
    Ann Rheum Dis; 1989 Apr; 48(4):302-6. PubMed ID: 2785367
    [Abstract] [Full Text] [Related]

  • 15. Complexes between C1q and C3 or C4: novel and specific markers for classical complement pathway activation.
    Wouters D, Wiessenberg HD, Hart M, Bruins P, Voskuyl A, Daha MR, Hack CE.
    J Immunol Methods; 2005 Mar; 298(1-2):35-45. PubMed ID: 15847795
    [Abstract] [Full Text] [Related]

  • 16. Alternative pathway complement activation in rheumatoid arthritis.
    El-Ghobarey A, Whaley K.
    J Rheumatol; 1980 Mar; 7(4):453-60. PubMed ID: 6158571
    [Abstract] [Full Text] [Related]

  • 17. Determination of complement breakdown fragments C3d and its subfragments in health and disease.
    Tamotsu M, Arai K, Fujita S, Hosotsubo K, Hayashi C, Miyai K, Miyano A, Kawanaka K, Takenaka M, Shimizu A.
    Diagn Immunol; 1984 Mar; 2(2):116-21. PubMed ID: 6333963
    [Abstract] [Full Text] [Related]

  • 18. Complement activation in acute coronary syndromes.
    Iltumur K, Karabulut A, Toprak G, Toprak N.
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [Abstract] [Full Text] [Related]

  • 19. [Correlation of hepatic necrosis and complement system activation in fulminant viral hepatitis].
    Hou J.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Feb; 15(1):49-54. PubMed ID: 8324837
    [Abstract] [Full Text] [Related]

  • 20. Complement activation and impaired capacity to solubilize immune complexes or to prevent their formation in essential mixed cryoglobulinemia.
    Corvetta A, Spaeth PJ, Ghirelli PA, Orecchioni F, Buetler R, Montroni M, Nydegger UE.
    Diagn Immunol; 1983 Feb; 1(4):315-23. PubMed ID: 6333960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.